Ibio, Inc. SEC filings IBIO

Ibio, Inc. has 909 filings in SEC EDGAR's recent list, going back to Mar 7, 2008. Its latest annual report, Form ARS, was filed on Sep 4, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on June 30.

Ibio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Oct 19, 2026 Oct 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 13, 2026 Oct 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 14, 2026 Sep 14, 2026
ARS Annual report to shareholders Sep 4, 2026 Jun 30, 2026
DEF 14A Proxy statement Sep 4, 2026 Sep 4, 2026
10-K Annual report Aug 28, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 28, 2026 Aug 28, 2026
PRE 14A Preliminary proxy statement Aug 20, 2026 Oct 14, 2026
8-K Current report
Officer or director change, Other events
Aug 4, 2026 Jul 31, 2026
8-K Current report
Other events
Jul 17, 2026 Jul 17, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 1, 2026 Jul 1, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 8, 2026 May 7, 2026
424B3 Prospectus Apr 29, 2026 —
8-K/A Amended current report
Other events
Apr 17, 2026 Apr 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 8, 2026 Apr 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 9, 2026 Mar 9, 2026
EFFECT Filing Mar 6, 2026 —
424B5 Prospectus supplement Mar 6, 2026 —
CORRESP Letter to the SEC Mar 4, 2026 —
UPLOAD Letter from the SEC Mar 4, 2026 —
8-K Current report
Material agreement, Agreement ended
Feb 27, 2026 Feb 23, 2026
S-3 Shelf registration Feb 27, 2026 —
10-Q Quarterly report Feb 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 10, 2026 Feb 10, 2026
EFFECT Filing Feb 9, 2026 —
424B3 Prospectus Feb 9, 2026 —
CORRESP Letter to the SEC Feb 5, 2026 —
UPLOAD Letter from the SEC Feb 5, 2026 —
S-3 Shelf registration Jan 30, 2026 —
D Filing Jan 22, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 12, 2026 Jan 8, 2026
8-K Current report
Shareholder vote results
Nov 21, 2025 Nov 20, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
10-Q/A Amended quarterly report Nov 17, 2025 Sep 30, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 30, 2025 Oct 30, 2025
ARS Annual report to shareholders Oct 6, 2025 Jun 30, 2025
DEF 14A Proxy statement Oct 6, 2025 Nov 20, 2025
10-K Annual report Sep 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Sep 5, 2025 Sep 5, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 21, 2025 Aug 19, 2025
424B5 Prospectus supplement Aug 21, 2025 —
8-K Current report
Results of operations, Other events
Aug 18, 2025 Aug 18, 2025
424B5 Prospectus supplement Aug 18, 2025 —
8-K Current report
Listing notice
Aug 1, 2025 Jul 29, 2025
424B3 Prospectus Jun 24, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2025 Jun 24, 2025
EFFECT Filing Jun 23, 2025 —
CORRESP Letter to the SEC Jun 18, 2025 —
UPLOAD Letter from the SEC Jun 18, 2025 —
8-K Current report
Other events
Jun 18, 2025 Jun 17, 2025
S-3 Shelf registration Jun 13, 2025 —
D Filing May 7, 2025 —
10-Q Quarterly report May 2, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 2, 2025 May 2, 2025
424B5 Prospectus supplement Apr 30, 2025 —
424B5 Prospectus supplement Apr 30, 2025 —
424B5 Prospectus supplement Apr 30, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 22, 2025 Apr 21, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 8, 2025 Apr 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 7, 2025 Apr 7, 2025
25 Form 25 Mar 3, 2025 —
CERT Filing Mar 3, 2025 —
8-A12B Form 8-a12b Mar 3, 2025 —
8-K Current report
Listing notice, Regulation FD disclosure
Feb 19, 2025 Feb 19, 2025
424B3 Prospectus Feb 11, 2025 —
EFFECT Filing Feb 10, 2025 —
10-Q Quarterly report Feb 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 10, 2025 Feb 10, 2025
CORRESP Letter to the SEC Feb 7, 2025 —
UPLOAD Letter from the SEC Feb 6, 2025 —
S-8 Employee stock plan registration Jan 31, 2025 —
S-3 Shelf registration Jan 31, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 13, 2025 Jan 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 2, 2025 Dec 31, 2024
8-K Current report
Results of operations, Shareholder vote results
Nov 25, 2024 Nov 21, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure
Oct 23, 2024 Oct 23, 2024
ARS Annual report to shareholders Oct 10, 2024 Jun 30, 2024
DEF 14A Proxy statement Oct 10, 2024 Oct 10, 2024
10-K/A Amended annual report Sep 24, 2024 Jun 30, 2024
10-K Annual report Sep 20, 2024 Jun 30, 2024
8-K Current report
Results of operations
Sep 20, 2024 Sep 20, 2024
EFFECT Filing Aug 6, 2024 —
424B5 Prospectus supplement Aug 6, 2024 —
CORRESP Letter to the SEC Aug 2, 2024 —
8-K Current report
Officer or director change
Jul 26, 2024 Jul 23, 2024
CORRESP Letter to the SEC Jul 25, 2024 —
S-3/A Filing Jul 25, 2024 —
UPLOAD Letter from the SEC Jul 18, 2024 —
8-K Current report
Officer or director change
Jul 9, 2024 Jul 2, 2024
8-K Current report
Material agreement
Jul 3, 2024 Jul 3, 2024
S-3 Shelf registration Jul 3, 2024 —
8-K Current report
Agreement ended, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Jun 5, 2024 May 31, 2024
8-K Current report
Regulation FD disclosure
Jun 3, 2024 Jun 3, 2024
8-K Current report
Material agreement, Unregistered share sale
May 20, 2024 May 14, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
424B3 Prospectus Apr 25, 2024 —
EFFECT Filing Apr 24, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
UPLOAD Letter from the SEC Apr 22, 2024 —
S-3 Shelf registration Apr 16, 2024 —
D Filing Apr 4, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Apr 1, 2024 Mar 26, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Feb 26, 2024 Feb 25, 2024
8-K Current report
Auditor change
Feb 21, 2024 Feb 15, 2024
10-Q Quarterly report Feb 9, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt
Jan 19, 2024 Jan 16, 2024
S-8 Employee stock plan registration Jan 10, 2024 —
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Dec 26, 2023 Dec 22, 2023
8-K Current report
Unregistered share sale, Other events
Dec 8, 2023 Dec 7, 2023
8-K Current report
Material agreement, Other events
Dec 6, 2023 Dec 5, 2023
424B3 Prospectus Dec 6, 2023 —
EFFECT Filing Dec 4, 2023 —
CORRESP Letter to the SEC Nov 30, 2023 —
S-1/A Amended registration statement Nov 30, 2023 —
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Nov 28, 2023 Nov 27, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
UPLOAD Letter from the SEC Nov 3, 2023 —
S-1 Registration statement Oct 27, 2023 —
ARS Annual report to shareholders Oct 26, 2023 Jun 30, 2023
DEF 14A Proxy statement Oct 26, 2023 Nov 27, 2023
PRE 14A Preliminary proxy statement Oct 16, 2023 Nov 27, 2023
8-K Current report
Material agreement
Oct 10, 2023 Oct 4, 2023
EFFECT Filing Oct 4, 2023 —
8-K Current report
Regulation FD disclosure
Oct 2, 2023 Oct 2, 2023
POS AM Filing Sep 29, 2023 —
8-K Current report
Results of operations
Sep 27, 2023 Sep 27, 2023
10-K Annual report Sep 27, 2023 Jun 30, 2023
8-K Current report
Material agreement, Results of operations, Other events
Sep 21, 2023 Sep 15, 2023
D Filing Aug 15, 2023 —
424B3 Prospectus Aug 14, 2023 —
EFFECT Filing Aug 11, 2023 —
CORRESP Letter to the SEC Aug 10, 2023 —
UPLOAD Letter from the SEC Aug 9, 2023 —
8-K Current report
Material agreement, Results of operations, Change to shareholder rights
Aug 7, 2023 Aug 4, 2023
424B5 Prospectus supplement Aug 7, 2023 —
S-1 Registration statement Aug 7, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Aug 4, 2023 Aug 4, 2023
8-K Current report
Regulation FD disclosure
Jul 10, 2023 Jul 10, 2023
8-K Current report
Officer or director change
Jun 27, 2023 Jun 22, 2023
8-K Current report
Other events
Jun 20, 2023 Jun 19, 2023
10-Q/A Amended quarterly report May 19, 2023 Dec 31, 2022
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Regulation FD disclosure
Apr 24, 2023 Apr 24, 2023
8-K Current report Apr 3, 2023 Mar 31, 2023
8-K Current report
Material agreement, New debt
Mar 30, 2023 Mar 24, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
424B3 Prospectus Feb 22, 2023 —
8-K Current report
Material agreement, New debt
Feb 21, 2023 Feb 20, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Exit or restructuring costs
Feb 16, 2023 Feb 10, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Jan 25, 2023 Jan 20, 2023
8-K Current report
Officer or director change
Jan 17, 2023 Jan 11, 2023
8-K Current report
Shareholder vote results, Other events
Dec 9, 2022 Dec 8, 2022
8-K Current report
Material agreement, Other events
Dec 8, 2022 Dec 6, 2022
424B5 Prospectus supplement Dec 8, 2022 —
8-K/A Amended current report
Officer or director change
Dec 7, 2022 Dec 1, 2022
424B5 Prospectus supplement Dec 6, 2022 —
DEFA14A Additional proxy material Dec 2, 2022 —
8-K Current report
Officer or director change
Dec 2, 2022 Dec 1, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Regulation FD disclosure
Nov 3, 2022 Nov 3, 2022
8-K Current report
Exit or restructuring costs, Officer or director change
Nov 3, 2022 Oct 31, 2022
DEF 14A Proxy statement Oct 26, 2022 Dec 8, 2022
8-K Current report
Other events
Oct 20, 2022 Oct 19, 2022
8-K Current report
Other events
Oct 14, 2022 Oct 11, 2022
10-K Annual report Oct 11, 2022 Jun 30, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Oct 7, 2022 Oct 7, 2022
8-K Current report
Regulation FD disclosure
Oct 3, 2022 Oct 3, 2022
NT 10-K Filing Sep 29, 2022 Jun 30, 2022
8-K Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change
Sep 27, 2022 Sep 27, 2022
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Sep 21, 2022 Sep 16, 2022
8-K Current report
Regulation FD disclosure
Aug 16, 2022 Aug 16, 2022
8-K Current report
Shareholder vote results
Jul 6, 2022 Jun 30, 2022
DEFR14A Filing Jun 14, 2022 —
DEFA14A Additional proxy material May 26, 2022 —
DEF 14A Proxy statement May 24, 2022 Jun 30, 2022
8-K Current report
Regulation FD disclosure
May 16, 2022 May 13, 2022
DEFA14A Additional proxy material May 13, 2022 —
DEFA14A Additional proxy material May 13, 2022 —
8-K Current report
Other events
May 13, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
PRE 14A Preliminary proxy statement May 12, 2022 Jun 30, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
May 12, 2022 May 9, 2022
8-K Current report
Officer or director change
May 2, 2022 Apr 28, 2022
8-K Current report
Regulation FD disclosure, Other events
Mar 18, 2022 Mar 16, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Bylaw or fiscal year change
Feb 1, 2022 Jan 26, 2022
8-K/A Amended current report
Shareholder vote results
Feb 1, 2022 Jan 31, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IBIO (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1420720
Former names
iBio, Inc. (until Oct 19, 2026); iBioPharma, Inc. (until Aug 14, 2009); InB:Biotechnologies, Inc. (until Jul 17, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.